TY - JOUR
T1 - Lysine 63 ubiquitination is involved in the progression of tubular damage in diabetic nephropathy
AU - Pontrelli, Paola
AU - Conserva, Francesca
AU - Papale, Massimo
AU - Oranger, Annarita
AU - Barozzino, Mariagrazia
AU - Vocino, Grazia
AU - Rocchetti, Maria Teresa
AU - Gigante, Margherita
AU - Castellano, Giuseppe
AU - Rossini, Michele
AU - Simone, Simona
AU - Laviola, Luigi
AU - Giorgino, Francesco
AU - Grandaliano, Giuseppe
AU - Di Paolo, Salvatore
AU - Gesualdo, Loreto
PY - 2017
Y1 - 2017
N2 - The purpose of our study was to evaluate how hyperglycemia (HG)influences Lys63 protein ubiquitination and its involvement in tubular damage and fibrosis in diabetic nephropathy (DN). Gene and protein expression of UBE2v1, a ubiquitin-conjugating E2-enzyme variant that mediates Lys63-linked ubiquitination, and Lys63-ubiquitinated proteins increased in HK2 tubular cells under HG. Matrix-assisted laser desorption/ionization-time of flight/tandemmass spectrometry identified 30 Lys63-ubiquitinated proteins, mainly involved in cellular organization, such as β-actin, whose Lys63 ubiquitination increased under HG, leading to cytoskeleton disorganization. This effect was reversed by the inhibitor of the Ubc13/UBE2v1 complexNSC697923. Western blot analysis confirmed that UBE2v1 silencing in HK2 under HG, restored Lys63-β-actin ubiquitination levels tothebasal condition. Immunohistochemistry on patients with type 2diabetic (T2D) revealed an increase in UBE2v1-and Lys63-ubiquitinatedproteins, particularly in kidneys of patients with DN compared with control kidneys and other non diabetic renal diseases, such as membranous nephropathy. Increased Lys63 ubiquitination both in vivo in patients with DN and in vitro, correlated with a-SMA expression, whereas UBE2v1 silencing reduced HG-induced a-SMA protein levels, returning them to basal expression. In conclusion, UBE2v1- and Lys63-ubiquitinated proteins increase in vitro under HG, as well as in vivo in T2D, is augmented in patients with DN, and may affect cytoskeleton organization and influence epithelial-to-mesenchymal transition. This process may drive the progression of tubular damage and interstitial fibrosis in patients with DN.
AB - The purpose of our study was to evaluate how hyperglycemia (HG)influences Lys63 protein ubiquitination and its involvement in tubular damage and fibrosis in diabetic nephropathy (DN). Gene and protein expression of UBE2v1, a ubiquitin-conjugating E2-enzyme variant that mediates Lys63-linked ubiquitination, and Lys63-ubiquitinated proteins increased in HK2 tubular cells under HG. Matrix-assisted laser desorption/ionization-time of flight/tandemmass spectrometry identified 30 Lys63-ubiquitinated proteins, mainly involved in cellular organization, such as β-actin, whose Lys63 ubiquitination increased under HG, leading to cytoskeleton disorganization. This effect was reversed by the inhibitor of the Ubc13/UBE2v1 complexNSC697923. Western blot analysis confirmed that UBE2v1 silencing in HK2 under HG, restored Lys63-β-actin ubiquitination levels tothebasal condition. Immunohistochemistry on patients with type 2diabetic (T2D) revealed an increase in UBE2v1-and Lys63-ubiquitinatedproteins, particularly in kidneys of patients with DN compared with control kidneys and other non diabetic renal diseases, such as membranous nephropathy. Increased Lys63 ubiquitination both in vivo in patients with DN and in vitro, correlated with a-SMA expression, whereas UBE2v1 silencing reduced HG-induced a-SMA protein levels, returning them to basal expression. In conclusion, UBE2v1- and Lys63-ubiquitinated proteins increase in vitro under HG, as well as in vivo in T2D, is augmented in patients with DN, and may affect cytoskeleton organization and influence epithelial-to-mesenchymal transition. This process may drive the progression of tubular damage and interstitial fibrosis in patients with DN.
KW - Amino Acid Sequence
KW - Biomarkers
KW - Cell Line
KW - Diabetic Nephropathies
KW - Diabetic kidney
KW - EMT
KW - Epithelial Cells
KW - Gene Expression Regulation
KW - Gene Silencing
KW - Humans
KW - Hyperglycemia
KW - Post-translational modifications
KW - Transcription Factors
KW - Ubiquitin-Conjugating Enzymes
KW - Ubiquitinated Proteins
KW - Ubiquitination
KW - Amino Acid Sequence
KW - Biomarkers
KW - Cell Line
KW - Diabetic Nephropathies
KW - Diabetic kidney
KW - EMT
KW - Epithelial Cells
KW - Gene Expression Regulation
KW - Gene Silencing
KW - Humans
KW - Hyperglycemia
KW - Post-translational modifications
KW - Transcription Factors
KW - Ubiquitin-Conjugating Enzymes
KW - Ubiquitinated Proteins
KW - Ubiquitination
UR - http://hdl.handle.net/10807/155031
U2 - 10.1096/fj.201600382RR
DO - 10.1096/fj.201600382RR
M3 - Article
SN - 0892-6638
VL - 31
SP - 308
EP - 319
JO - THE FASEB JOURNAL
JF - THE FASEB JOURNAL
ER -